- Three changes to the FTSE 100
- Fresnillo, Intermediate Capital Group and Pennon Group to join FTSE 100
- 11 changes to the FTSE 250
FTSE Russell, the global index provider, confirms today that Fresnillo, Intermediate Capital Group and Pennon Group will be joining the FTSE 100 Index as a result of the March 2020 quarterly review. In the rebalance, Kingfisher, NMC Health* and TUI AG will leave the FTSE 100 index and enter the FTSE 250 index.
The rules-driven, impartial quarterly reviews ensure the indexes continue to portray an accurate reflection of the market they represent and form an essential component to the management of the indexes.
The FTSE 250 Index will see the following changes (in alphabetical order), in addition to the amendments described above.
Entering FTSE 250 Index (Additions)
- Chemring Group
- Gamesys Group
- Hipgnosis Songs Fund
- Impax Environmental Markets
- NMC Health*
- TUI AG
- XP Power
Exiting FTSE 250 Index (Deletions)
- 888 Holdings
- Galliford Try Holdings
- Intermediate Capital Group
- NewRiver REIT
- Pennon Group
- Restaurant Group
- Tullow Oil
FTSE Russell operates a reserve list for the FTSE 100 Index, to be used in the event of a corporate action occurring between reviews e.g. merger, acquisition, delisting or suspension. In such cases, the reserve list constituent with the largest market capitalisation (on the date of the corporate action) will replace the outgoing constituent. With immediate effect, the following reserve list for FTSE 100 will be used (in alphabetical order):
- Derwent London
- Direct Line Insurance Group
- GVC Holdings
All changes from this review will be implemented at the close of business on Friday, 20 March 2020 and take effect from the start of trading on Monday, 23 March 2020.
A link to the full technical notice can be found here.
* NMC Health
Due to its ongoing suspension from trading, NMC Health will be temporarily retained within the FTSE 100 and its inclusion to the FTSE 250 delayed, if the suspension remains in place at the time of the review effective date. The changes will be implemented upon resumption of trading, with appropriate notice.
For additional reference:
Tuesday 03 March 2020 (after market close) – FTSE UK Index Series Review rank date:
NMC Health was ranked based on its last traded price of 938.40p and was consequently ranked as an auto exclusion from the FTSE 100 (i.e. a removal from the FTSE 100 and addition to the FTSE 250).
Friday 20 March 2020 (after market close):
If NMC Health has resumed trading by close of business on Wednesday 18 March 2020, all FTSE UK Index Series review changes communicated on Wednesday 04 March 2020 will be implemented as announced.
If NMC Health has not resumed trading by close of business on Wednesday 18 March 2020, NMC Health will be retained within its current index membership (i.e. FTSE 100) over the index review effective date, until such time it resumes trading.
If NMC resumes trading on Thursday 19 March 2020 or Friday 20 March 2020, it will be removed from the FTSE 100 (and added to the FTSE 250) with the provision of two days’ notice and therefore subsequent to the review effective date.
As a result, the FTSE 100 will consist of 101 companies from the review implementation date until the removal of NMC Health; and the FTSE 250 will include 249 companies until the addition of NMC Health.
Lucie Holloway/ Nandeep Roopray
+44 (0)20 7797 1222
FTSE Russell is a global index leader that provides innovative benchmarking, analytics and data solutions for investors worldwide. FTSE Russell calculates thousands of indexes that measure and benchmark markets and asset classes in more than 70 countries, covering 98% of the investable market globally.
FTSE Russell index expertise and products are used extensively by institutional and retail investors globally. Approximately $15 trillion is currently benchmarked to FTSE Russell indexes. For over 30 years, leading asset owners, asset managers, ETF providers and investment banks have chosen FTSE Russell indexes to benchmark their investment performance and create ETFs, structured products and index-based derivatives.
A core set of universal principles guides FTSE Russell index design and management: a transparent rules-based methodology is informed by independent committees of leading market participants. FTSE Russell is focused on applying the highest industry standards in index design and governance and embraces the IOSCO Principles. FTSE Russell is also focused on index innovation and customer partnerships as it seeks to enhance the breadth, depth and reach of its offering.
For more information, visit www.ftserussell.com
© 2020 London Stock Exchange Group plc and its applicable group undertakings (the “LSE Group”). The LSE Group includes (1) FTSE International Limited (“FTSE”), (2) Frank Russell Company (“Russell”), (3) FTSE Global Debt Capital Markets Inc. and FTSE Global Debt Capital Markets Limited (together, “FTSE Canada”), (4) MTSNext Limited (“MTSNext”), (5) Mergent, Inc. (“Mergent”), (6) FTSE Fixed Income LLC (“FTSE FI”), (7) The Yield Book Inc (“YB”) and (8) Beyond Ratings S.A.S. (“BR”). All rights reserved.
FTSE Russell® is a trading name of FTSE, Russell, FTSE Canada, MTSNext, Mergent, FTSE FI, YB and BR. “FTSE®”, “Russell®”, “FTSE Russell®”, “MTS®”, “FTSE4Good®”, “ICB®”, “Mergent®”, “The Yield Book®”, “Beyond Ratings®” and all other trademarks and service marks used herein (whether registered or unregistered) are trademarks and/or service marks owned or licensed by the applicable member of the LSE Group or their respective licensors and are owned, or used under licence, by FTSE, Russell, MTSNext, FTSE Canada, Mergent, FTSE FI, YB or BR. FTSE International Limited is authorised and regulated by the Financial Conduct Authority as a benchmark administrator.
All information is provided for information purposes only. All information and data contained in this publication is obtained by the LSE Group, from sources believed by it to be accurate and reliable. Because of the possibility of human and mechanical error as well as other factors, however, such information and data is provided "as is" without warranty of any kind. No member of the LSE Group nor their respective directors, officers, employees, partners or licensors make any claim, prediction, warranty or representation whatsoever, expressly or impliedly, either as to the accuracy, timeliness, completeness, merchantability of any information or of results to be obtained from the use of FTSE Russell products, including but not limited to indexes, data and analytics, or the fitness or suitability of the FTSE Russell products for any particular purpose to which they might be put. Any representation of historical data accessible through FTSE Russell products is provided for information purposes only and is not a reliable indicator of future performance.
No responsibility or liability can be accepted by any member of the LSE Group nor their respective directors, officers, employees, partners or licensors for (a) any loss or damage in whole or in part caused by, resulting from, or relating to any error (negligent or otherwise) or other circumstance involved in procuring, collecting, compiling, interpreting, analysing, editing, transcribing, transmitting, communicating or delivering any such information or data or from use of this document or links to this document or (b) any direct, indirect, special, consequential or incidental damages whatsoever, even if any member of the LSE Group is advised in advance of the possibility of such damages, resulting from the use of, or inability to use, such information. No member of the LSE Group nor their respective directors, officers, employees, partners or licensors provide investment advice and nothing contained herein or accessible through FTSE Russell products, including statistical data and industry reports, should be taken as constituting financial or investment advice or a financial promotion.
Past performance is no guarantee of future results. Charts and graphs are provided for illustrative purposes only. Index returns shown may not represent the results of the actual trading of investable assets. Certain returns shown may reflect back-tested performance. All performance presented prior to the index inception date is back-tested performance. Back-tested performance is not actual performance, but is hypothetical. The back-test calculations are based on the same methodology that was in effect when the index was officially launched. However, back-tested data may reflect the application of the index methodology with the benefit of hindsight, and the historic calculations of an index may change from month to month based on revisions to the underlying economic data used in the calculation of the index. This document may contain forward-looking assessments. These are based upon a number of assumptions concerning future conditions that ultimately may prove to be inaccurate. Such forward-looking assessments are subject to risks and uncertainties and may be affected by various factors that may cause actual results to differ materially. No member of the LSE Group nor their licensors assume any duty to and do not undertake to update forward-looking assessments. No part of this information may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the applicable member of the LSE Group. Use and distribution of the LSE Group data requires a licence from FTSE, Russell, FTSE Canada, MTSNext, Mergent, FTSE FI, YB, BR and/or their respective licensors.